The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Single-Use Technologies for the Biologic-Global Market Insights and Sales Trends 2024
Synopsis
Single-use technologies are widely used in the biotherapeutic market to reduce risk and improve operational efficiencies.
The global Single-Use Technologies for the Biologic market size is expected to reach US$ 8472.9 million by 2029, growing at a CAGR of 9.9% from 2023 to 2029. The market is mainly driven by the significant applications of Single-Use Technologies for the Biologic in various end use industries. The expanding demands from the Monoclonal Antibodies, Vaccines, Gene Therapy and Recombinant Proteins, are propelling Single-Use Technologies for the Biologic market. Membrane Adsorber, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bioreactors segment is estimated at % CAGR for the next seven-year period.
Rising awareness about therapeutic applications of biotherapeutics is a key driver for the global single-use technologies market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Single-Use Technologies for the Biologic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Single-Use Technologies for the Biologic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Single-Use Technologies for the Biologic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Single-Use Technologies for the Biologic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Single-Use Technologies for the Biologic covered in this report include Thermo Fisher Scientific, Applikon Biotechnology, GE Healthcare, Pall, BioPure Technology, Sartorius, Novasep, W. L. Gore and Associates and EMD Millipore, etc.
The global Single-Use Technologies for the Biologic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Applikon Biotechnology
GE Healthcare
Pall
BioPure Technology
Sartorius
Novasep
W. L. Gore and Associates
EMD Millipore
DowDuPont
Global Single-Use Technologies for the Biologic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Single-Use Technologies for the Biologic market, Segment by Type:
Membrane Adsorber
Bioreactors
Disposable Mixing Systems
Tangential Flow Filtration
Tubing and Connectors
Depth Filtration
Buffer Containers
Waste Containers
Global Single-Use Technologies for the Biologic market, by Application
Monoclonal Antibodies
Vaccines
Gene Therapy
Recombinant Proteins
Blood Derivatives
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Single-Use Technologies for the Biologic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Single-use technologies are widely used in the biotherapeutic market to reduce risk and improve operational efficiencies.
The global Single-Use Technologies for the Biologic market size is expected to reach US$ 8472.9 million by 2029, growing at a CAGR of 9.9% from 2023 to 2029. The market is mainly driven by the significant applications of Single-Use Technologies for the Biologic in various end use industries. The expanding demands from the Monoclonal Antibodies, Vaccines, Gene Therapy and Recombinant Proteins, are propelling Single-Use Technologies for the Biologic market. Membrane Adsorber, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bioreactors segment is estimated at % CAGR for the next seven-year period.
Rising awareness about therapeutic applications of biotherapeutics is a key driver for the global single-use technologies market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Single-Use Technologies for the Biologic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Single-Use Technologies for the Biologic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Single-Use Technologies for the Biologic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Single-Use Technologies for the Biologic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Single-Use Technologies for the Biologic covered in this report include Thermo Fisher Scientific, Applikon Biotechnology, GE Healthcare, Pall, BioPure Technology, Sartorius, Novasep, W. L. Gore and Associates and EMD Millipore, etc.
The global Single-Use Technologies for the Biologic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Applikon Biotechnology
GE Healthcare
Pall
BioPure Technology
Sartorius
Novasep
W. L. Gore and Associates
EMD Millipore
DowDuPont
Global Single-Use Technologies for the Biologic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Single-Use Technologies for the Biologic market, Segment by Type:
Membrane Adsorber
Bioreactors
Disposable Mixing Systems
Tangential Flow Filtration
Tubing and Connectors
Depth Filtration
Buffer Containers
Waste Containers
Global Single-Use Technologies for the Biologic market, by Application
Monoclonal Antibodies
Vaccines
Gene Therapy
Recombinant Proteins
Blood Derivatives
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Single-Use Technologies for the Biologic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Single-Use Technologies for the Biologic
1.1 Single-Use Technologies for the Biologic Market Overview
1.1.1 Single-Use Technologies for the Biologic Product Scope
1.1.2 Single-Use Technologies for the Biologic Market Status and Outlook
1.2 Global Single-Use Technologies for the Biologic Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Single-Use Technologies for the Biologic Market Size by Region (2018-2029)
1.4 Global Single-Use Technologies for the Biologic Historic Market Size by Region (2018-2023)
1.5 Global Single-Use Technologies for the Biologic Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Single-Use Technologies for the Biologic Market Size (2018-2029)
1.6.1 North America Single-Use Technologies for the Biologic Market Size (2018-2029)
1.6.2 Europe Single-Use Technologies for the Biologic Market Size (2018-2029)
1.6.3 Asia-Pacific Single-Use Technologies for the Biologic Market Size (2018-2029)
1.6.4 Latin America Single-Use Technologies for the Biologic Market Size (2018-2029)
1.6.5 Middle East & Africa Single-Use Technologies for the Biologic Market Size (2018-2029)
2 Single-Use Technologies for the Biologic Market by Type
2.1 Introduction
2.1.1 Membrane Adsorber
2.1.2 Bioreactors
2.1.3 Disposable Mixing Systems
2.1.4 Tangential Flow Filtration
2.1.5 Tubing and Connectors
2.1.6 Depth Filtration
2.1.7 Buffer Containers
2.1.8 Waste Containers
2.2 Global Single-Use Technologies for the Biologic Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Single-Use Technologies for the Biologic Historic Market Size by Type (2018-2023)
2.2.2 Global Single-Use Technologies for the Biologic Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Single-Use Technologies for the Biologic Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Single-Use Technologies for the Biologic Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Single-Use Technologies for the Biologic Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Single-Use Technologies for the Biologic Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Single-Use Technologies for the Biologic Revenue Breakdown by Type (2018-2029)
3 Single-Use Technologies for the Biologic Market Overview by Application
3.1 Introduction
3.1.1 Monoclonal Antibodies
3.1.2 Vaccines
3.1.3 Gene Therapy
3.1.4 Recombinant Proteins
3.1.5 Blood Derivatives
3.2 Global Single-Use Technologies for the Biologic Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Single-Use Technologies for the Biologic Historic Market Size by Application (2018-2023)
3.2.2 Global Single-Use Technologies for the Biologic Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Single-Use Technologies for the Biologic Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Single-Use Technologies for the Biologic Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Single-Use Technologies for the Biologic Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Single-Use Technologies for the Biologic Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Single-Use Technologies for the Biologic Revenue Breakdown by Application (2018-2029)
4 Single-Use Technologies for the Biologic Competition Analysis by Players
4.1 Global Single-Use Technologies for the Biologic Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Single-Use Technologies for the Biologic as of 2022)
4.3 Date of Key Players Enter into Single-Use Technologies for the Biologic Market
4.4 Global Top Players Single-Use Technologies for the Biologic Headquarters and Area Served
4.5 Key Players Single-Use Technologies for the Biologic Product Solution and Service
4.6 Competitive Status
4.6.1 Single-Use Technologies for the Biologic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific Single-Use Technologies for the Biologic Products, Services and Solutions
5.1.4 Thermo Fisher Scientific Single-Use Technologies for the Biologic Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Applikon Biotechnology
5.2.1 Applikon Biotechnology Profile
5.2.2 Applikon Biotechnology Main Business
5.2.3 Applikon Biotechnology Single-Use Technologies for the Biologic Products, Services and Solutions
5.2.4 Applikon Biotechnology Single-Use Technologies for the Biologic Revenue (US$ Million) & (2018-2023)
5.2.5 Applikon Biotechnology Recent Developments
5.3 GE Healthcare
5.3.1 GE Healthcare Profile
5.3.2 GE Healthcare Main Business
5.3.3 GE Healthcare Single-Use Technologies for the Biologic Products, Services and Solutions
5.3.4 GE Healthcare Single-Use Technologies for the Biologic Revenue (US$ Million) & (2018-2023)
5.3.5 Pall Recent Developments
5.4 Pall
5.4.1 Pall Profile
5.4.2 Pall Main Business
5.4.3 Pall Single-Use Technologies for the Biologic Products, Services and Solutions
5.4.4 Pall Single-Use Technologies for the Biologic Revenue (US$ Million) & (2018-2023)
5.4.5 Pall Recent Developments
5.5 BioPure Technology
5.5.1 BioPure Technology Profile
5.5.2 BioPure Technology Main Business
5.5.3 BioPure Technology Single-Use Technologies for the Biologic Products, Services and Solutions
5.5.4 BioPure Technology Single-Use Technologies for the Biologic Revenue (US$ Million) & (2018-2023)
5.5.5 BioPure Technology Recent Developments
5.6 Sartorius
5.6.1 Sartorius Profile
5.6.2 Sartorius Main Business
5.6.3 Sartorius Single-Use Technologies for the Biologic Products, Services and Solutions
5.6.4 Sartorius Single-Use Technologies for the Biologic Revenue (US$ Million) & (2018-2023)
5.6.5 Sartorius Recent Developments
5.7 Novasep
5.7.1 Novasep Profile
5.7.2 Novasep Main Business
5.7.3 Novasep Single-Use Technologies for the Biologic Products, Services and Solutions
5.7.4 Novasep Single-Use Technologies for the Biologic Revenue (US$ Million) & (2018-2023)
5.7.5 Novasep Recent Developments
5.8 W. L. Gore and Associates
5.8.1 W. L. Gore and Associates Profile
5.8.2 W. L. Gore and Associates Main Business
5.8.3 W. L. Gore and Associates Single-Use Technologies for the Biologic Products, Services and Solutions
5.8.4 W. L. Gore and Associates Single-Use Technologies for the Biologic Revenue (US$ Million) & (2018-2023)
5.8.5 W. L. Gore and Associates Recent Developments
5.9 EMD Millipore
5.9.1 EMD Millipore Profile
5.9.2 EMD Millipore Main Business
5.9.3 EMD Millipore Single-Use Technologies for the Biologic Products, Services and Solutions
5.9.4 EMD Millipore Single-Use Technologies for the Biologic Revenue (US$ Million) & (2018-2023)
5.9.5 EMD Millipore Recent Developments
5.10 DowDuPont
5.10.1 DowDuPont Profile
5.10.2 DowDuPont Main Business
5.10.3 DowDuPont Single-Use Technologies for the Biologic Products, Services and Solutions
5.10.4 DowDuPont Single-Use Technologies for the Biologic Revenue (US$ Million) & (2018-2023)
5.10.5 DowDuPont Recent Developments
6 North America
6.1 North America Single-Use Technologies for the Biologic Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Single-Use Technologies for the Biologic Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Single-Use Technologies for the Biologic Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Single-Use Technologies for the Biologic Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Single-Use Technologies for the Biologic Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Single-Use Technologies for the Biologic Market Dynamics
11.1 Single-Use Technologies for the Biologic Industry Trends
11.2 Single-Use Technologies for the Biologic Market Drivers
11.3 Single-Use Technologies for the Biologic Market Challenges
11.4 Single-Use Technologies for the Biologic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
